Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| GupShup | 2025 | Venture - Series Unknown | $60.0M | San Francisco |
| Retym | 2025 | Series D | $75.0M | Cupertino |
| 73 Strings | 2025 | Series B | $55.0M | Paris |
| Frore Systems | 2024 | Series C | $80.0M | San Jose |
| GO | 2023 | Series D | Undisclosed | Tokyo |
| Evozyne | 2023 | Series B | $81.0M | Chicago |
| GenePlanet | 2023 | Series B | $22.4M | Ljubljana |
| Moloco | 2023 | Series D | $24.2M | Redwood City |
| Gridwealth | 2023 | Venture - Series Unknown | $30.0M | Boston |
| Moonfare | 2023 | Series C | $15.0M | Berlin |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | GupShup | Venture - Series Unknown | $60.0M | San Francisco, United States |
| 52 | Retym | Series D | $75.0M | Cupertino, United States |
| 53 | 73 Strings | Series B | $55.0M | Paris, France |
| 54 | Frore Systems | Series C | $80.0M | San Jose, United States |
| 55 | GO | Series D | Undisclosed | Tokyo, Japan |
| 56 | Evozyne | Series B | $81.0M | Chicago, United States |
| 57 | GenePlanet | Series B | $22.4M | Ljubljana, Slovenia |
| 58 | Moloco | Series D | $24.2M | Redwood City, United States |
| 59 | Gridwealth | Venture - Series Unknown | $30.0M | Boston, United States |
| 60 | Moonfare | Series C | $15.0M | Berlin, Germany |
Gupshup offers a platform for businesses to build AI-powered messaging, chatbots, and customer engagement.
Retym is a semiconductor startup that builds semiconductor technology to transform the data center and telecommunications industries.
73 Strings provides financial advisory services using artificial intelligence and technology solutions.
Frore Systems is a developer of thermal technology for consumer devices.
GO is a developer of both software and hardware in the field of transportation and mobility based on a taxi system.
Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.
GenePlanet is a European company active in the field of biotechnology, specializing in genetic testing and research.
Moloco offers programmatic advertising solutions to help optimize the client's acquisition, retention, and monetization campaigns.
Gridwealth lowers GHG emissions while generating long-term cash for customer buildings.
Moonfare is a digital platform that provides HNWI, family offices, banks and their advisors access to top-tier private markets investments.
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Asimov employs artificial intelligence to develop tools for the design and manufacture of next-generation therapeutics.
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.
Nikola Motor Company manufactures heavy-duty commercial battery-electric vehicles, fuel-cell electric vehicles, and energy solutions.
Cleerly is a digital healthcare company that offers heart disease diagnosis solutions.
Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
Inscripta is a life science technology company that develops digital genome engineering solutions.
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.
IperionX is a leading American titanium metal and critical materials company.
CollegeVine is a platform for deploying AI Agents to replace administrative work throughout the higher education sector.
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.
Astera Labs is a semiconductor company that provides connectivity solutions for intelligent systems.
Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.
Fidelity has invested in 209 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Fidelity's top investment sectors include Biotechnology, Health Care, Artificial Intelligence (AI), Manufacturing, Therapeutics. The firm invests across 43 different industry categories.
Among tracked funding rounds, Mirador Therapeutics received $250.0M in a Series B round. Fidelity's total known invested capital is $15.5B.
Fidelity's average investment size is $140.8M across its portfolio of 209 companies.
Recent Fidelity portfolio additions include GupShup, Retym, 73 Strings, Frore Systems, GO. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors